SAN FRANCISCO, CA – April 27, 2016 – Aktana, the pioneer in decision support for global life science companies, today announced that it has been named a “Cool Vendor” by Gartner Inc. based on the April 15, 2016 report entitled “Cool Vendors in Life Science, 2016” by analysts Michael Shanler and Stephen Davies.
Aktana currently supports seven of the world’s top 15 pharmaceutical companies, improving their commercial effectiveness by delivering data-driven insights and suggestions directly to sales reps. Once a game plan has been developed based on a company’s existing strategy, Aktana’s Decision Support Engine (DSE) is configured to examine market data and cross-channel activity, and identify best actions and supporting insights. Empowered with these suggestions right in their CRM workflow, reps can focus on building stronger physician relationships and generating improved results.
“We’re honored to be named a Cool Vendor by Gartner. Recognition is especially rewarding when a team charts out a new vision and works hard to turn it into reality,” said David Ehrlich, CEO, Aktana. “This acknowledgement, coupled with the trust placed in us by nearly half of the top 15 global pharma companies, brings due attention to the role decision support can play in helping customers improve their commercial effectiveness.”
Read about the 2016 Cool Vendors in Life Science on Michael’s blog here.
Access the full report by analysts Michael Shanler and Stephen Davies here (for Gartner clients).
Access the eBook, “Bringing Clarity to Chaos: How Decision Support Programs Can Dramatically Improve Your Sales Results” here.
Cool Vendor Disclaimer:
Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.